Miro clears TGA audit ahead of Crohn’s disease trial
Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.
Lean: Leans left
Fact-focusedFactuality: HighCountry: AustraliaFunding: CorporateOwner: Nine Entertainment
Coverage breakdown
Funding
Corporate
Countries
Australia
Media ownership
Nine Entertainment
Avg reliability78
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 42 (Limited corroboration)
Propaganda risk: 0
Trending: Low
Sources: 1
Reliability: 78
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 0
Amplification: 0